BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11553971)

  • 1. The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress.
    Friedman A; Galazka-Friedman J
    Adv Neurol; 2001; 86():137-42. PubMed ID: 11553971
    [No Abstract]   [Full Text] [Related]  

  • 2. [Iron homeostasis and Parkinson's disease].
    Faucheux BA; Hirsch EC
    Ann Biol Clin (Paris); 1998 Jul; 56 Spec No():23-30. PubMed ID: 9827211
    [No Abstract]   [Full Text] [Related]  

  • 3. What process causes nigral cell death in Parkinson's disease?
    Jenner P
    Neurol Clin; 1992 May; 10(2):387-403. PubMed ID: 1584181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease.
    Floor E
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):709-20. PubMed ID: 10875434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress.
    Singh C; Ahmad I; Kumar A
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):19-28. PubMed ID: 17543230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free radical and nitric oxide toxicity in Parkinson's disease.
    Przedborski S; Jackson-Lewis V; Vila M; Wu DC; Teismann P; Tieu K; Choi DK; Cohen O
    Adv Neurol; 2003; 91():83-94. PubMed ID: 12442666
    [No Abstract]   [Full Text] [Related]  

  • 7. [Etiology and pathogenesis of parkinson's disease].
    Mizuno Y; Ikebe S; Mochizuki H; Matumine H; Kondo T
    No To Shinkei; 1996 Jan; 48(1):5-17. PubMed ID: 8679319
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An introduction to the free radical hypothesis in Parkinson's disease.
    Olanow CW
    Ann Neurol; 1992; 32 Suppl():S2-9. PubMed ID: 1510376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron as a cause of Parkinson disease - a myth or a well established hypothesis?
    Friedman A; Galazka-Friedman J; Koziorowski D
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S212-4. PubMed ID: 20082993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Free radicals and ailing proteins--the culprits behind Parkinson disease?].
    Smith R; Lotharius J; Brundin P
    Lakartidningen; 2003 Apr; 100(15):1324-6, 1329-30. PubMed ID: 12739402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
    Zecca L; Casella L; Albertini A; Bellei C; Zucca FA; Engelen M; Zadlo A; Szewczyk G; Zareba M; Sarna T
    J Neurochem; 2008 Aug; 106(4):1866-75. PubMed ID: 18624918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.
    Fitzmaurice PS; Ang L; Guttman M; Rajput AH; Furukawa Y; Kish SJ
    Mov Disord; 2003 Sep; 18(9):969-76. PubMed ID: 14502663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte mitochondria: a substrate for iron deposition in the aging rat substantia nigra.
    Schipper HM; Vininsky R; Brull R; Small L; Brawer JR
    Exp Neurol; 1998 Aug; 152(2):188-96. PubMed ID: 9710517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control.
    Koziorowski D; Friedman A; Arosio P; Santambrogio P; Dziewulska D
    Parkinsonism Relat Disord; 2007 May; 13(4):214-8. PubMed ID: 17275395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifications of the iron-neuromelanin system in Parkinson's disease.
    Fasano M; Bergamasco B; Lopiano L
    J Neurochem; 2006 Feb; 96(4):909-16. PubMed ID: 16417570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores.
    Atasoy HT; Nuyan O; Tunc T; Yorubulut M; Unal AE; Inan LE
    Neurol India; 2004 Sep; 52(3):332-7. PubMed ID: 15472421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pumping iron in Parkinson's disease.
    Bonn D
    Lancet; 1996 Jun; 347(9015):1614. PubMed ID: 8667877
    [No Abstract]   [Full Text] [Related]  

  • 20. Iron, free radicals, and oxidative injury.
    McCord JM
    Semin Hematol; 1998 Jan; 35(1):5-12. PubMed ID: 9460805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.